scholarly article | Q13442814 |
P50 | author | Shahrokh Shariat | Q7462263 |
Eugene K. Cha | Q37839556 | ||
P2093 | author name string | Arnulf Stenzl | |
Paul J Christos | |||
Christian Schwentner | |||
Joerg Hennenlotter | |||
Armin Pycha | |||
Bernd J Schmitz-Dräger | |||
Thomas Martini | |||
Lenuta-Ancuta Tirsar | |||
Christine Mian | |||
P2860 | cites work | Decision curve analysis: a novel method for evaluating prediction models | Q34581068 |
Comparisons of nomograms and urologists' predictions in prostate cancer | Q34638482 | ||
Urine markers for bladder cancer surveillance: a systematic review | Q36144538 | ||
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder | Q37158767 | ||
Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladder | Q39211380 | ||
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors | Q39605793 | ||
The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee | Q40831782 | ||
Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up | Q46156479 | ||
Patterns of hematuria referral to urologists: does a gender disparity exist? | Q51694266 | ||
Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. | Q52933297 | ||
Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer | Q59649685 | ||
Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study | Q78953902 | ||
Immunocytology in the assessment of patients with asymptomatic microhaematuria | Q79362303 | ||
Immunocytology in the assessment of patients with asymptomatic hematuria | Q80187307 | ||
Performance of urine test in patients monitored for recurrence of bladder cancer: a multicenter study in the United States | Q81170464 | ||
uCyt+/ImmunoCyt in the detection of recurrent urothelial carcinoma: an update on 1991 analyses | Q82255240 | ||
Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder | Q82853564 | ||
Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey | Q83038592 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | multicenter clinical trial | Q6934595 |
bladder cancer | Q504775 | ||
P304 | page(s) | 185-192 | |
P577 | publication date | 2011-09-09 | |
P1433 | published in | European Urology | Q15763991 |
P1476 | title | Immunocytology is a strong predictor of bladder cancer presence in patients with painless hematuria: a multicentre study | |
P478 | volume | 61 |
Q89184326 | An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer |
Q51297927 | Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma. |
Q38177471 | Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer |
Q38650676 | Current Status of Urinary Biomarkers for Detection and Surveillance of Bladder Cancer |
Q47103658 | Cytokeratin 20/p53 dual immunocytochemistry for improving the diagnostic accuracy of urine liquid-based cytology in the detection of urothelial neoplasm: A retrospective study |
Q38511509 | Developing proteomic biomarkers for bladder cancer: towards clinical application |
Q54449190 | Evaluation of a new quantitative point-of-care test platform for urine-based detection of bladder cancer. |
Q39177122 | Evaluation of double immunocytochemical staining for CK20 and P53 as a potential adjunct to cytology for urothelial cancer diagnosis |
Q38957991 | Microhematuria assessment an IBCN consensus-Based upon a critical review of current guidelines |
Q91794064 | Molecular markers in bladder cancer |
Q47721208 | The contemporary role and impact of urine-based biomarkers in bladder cancer |
Q35021819 | The use of molecular analyses in voided urine for the assessment of patients with hematuria. |
Q58705097 | Urinary Biomarkers in the Evaluation of Primary Hematuria: A Systematic Review and Meta-Analysis |
Q38195145 | Urinary immunocytology--promise or nonseller? A review with an opinion |
Q45139625 | Urine cytology - update 2013. A systematic review of recent literature |
Q38140308 | Urine markers for detection and surveillance of bladder cancer |